Chemicals Firm Tatva Chintan to Source 6.4 MW of Wind-Solar Power from AMPIN

The company will acquire a 10.99% stake in AMPIN’s SPV

February 19, 2026

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights

Save

Chemical manufacturing company Tatva Chintan Pharma Chem has signed agreements to procure 6.4 MW of power from AMPIN C&I Power Twenty Six’s (AMPIN) 19.8 MW wind-solar hybrid group captive project in Gujarat.

ℹ️ This article is free for registered users. Sign in to continue reading.

Sign In to Continue Reading

Create a free account to access the full article and exclusive features from Mercom India's renewable energy coverage.

✓Access to free articles and news

✓Save articles for later reading

✓Personalized content recommendations

✓Newsletter subscriptions

Already a subscriber? Sign In

Melvin Mathew

Get the most relevant India solar and clean energy news.

Chemicals Firm Tatva Chintan to Source 6.4 MW of Wind-Solar Power from AMPIN

Sign In to Continue Reading

Get the most relevant India solar and clean energy news.

RECENT POSTS